Abstract
Sarcomas represent a heterogeneous group of tumors with different natural histories and therapeutic approaches. Recent discoveries have identified molecular alterations in the pathogenesis of these tumors that lead to distinct effects on sarcoma cell biology. These tumor cell characteristics include independence from growth factors, evasion of apoptosis, and maintenance of genomic integrity. Inhibition of these molecular alterations represents a therapeutic opportunity to reverse the biologic basis of tumor formation in soft-tissue sarcomas and bone tumors.
Original language | English (US) |
---|---|
Pages (from-to) | 295-303 |
Number of pages | 9 |
Journal | Current oncology reports |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2003 |
ASJC Scopus subject areas
- Oncology